Kisho

Glaxo Wellcome Inc. — Rare Disease Pipeline | Kisho | Kisho

Glaxo Wellcome Inc.

Other

Orphan Designations

FDA Approvals

Rare Diseases

News Articles

Disease	Drug(s)	Designation	Approved
AIDS	Retrovir	Orphan Designation	-
AIDS dementia complex	Mepron	Orphan Designation	-
AIDS-related disorder	Mepron	Orphan Designation	-
Bailey-Bloch congenital myopathy	Epoprostenol	Orphan Designation	-
COVID-19–associated multisystem inflammatory syndrome in children	Digibind	Orphan Designation	-
Ehlers-Danlos syndrome, classic type, 1	Exosurf Neonatal for Intratracheal Suspension	Orphan Designation	-
Ehlers-Danlos syndrome, dermatosparaxis type	Exosurf Neonatal for Intratracheal Suspension	Orphan Designation	-
Emanuel syndrome	Flolan	Orphan Designation	-
HIV-associated nephropathy	Mepron	Orphan Designation	-
Kaposi's sarcoma	Mepron	Orphan Designation	-
Larsen-like syndrome, B3GAT3 type	Alkeran For Injection	Orphan Designation	-
PEHO syndrome	Digibind	Orphan Designation	-
Pearson syndrome	Carbovir	Orphan Designation	-
advanced heart failure	Retrovir	Orphan Designation	-
advanced sleep phase syndrome	Retrovir	Orphan Designation	-
advanced sleep phase syndrome 1	Retrovir	Orphan Designation	-
advanced sleep phase syndrome 3	Retrovir	Orphan Designation	-
alopecia-intellectual disability syndrome 2	Mepron	Orphan Designation	-
anogenital human papillomavirus infection	Interferon alfa-nl	Orphan Designation	-
autosomal recessive congenital ichthyosis 11	Monolaurin	Orphan Designation	-
bilirubin induced brain injury in the newborn	Exosurf Neonatal for Intratracheal Suspension	Orphan Designation	-
bronchiectasis with or without elevated sweat chloride 2	Digibind	Orphan Designation	-
central nervous system AIDS arteritis	Mepron	Orphan Designation	-
chronic primary adrenal insufficiency	Flolan	Orphan Designation	-
classic stiff person syndrome	CarbovirFlolan	Orphan Designation	-
colorectal cancer	Retrovir	Orphan Designation	-
congenital contractural arachnodactyly	Alkeran For Injection	Orphan Designation	-
congenital heart defects, multiple types, 8, with or without heterotaxy	Alkeran For Injection	Orphan Designation	-
congenital primary megaureter	Monolaurin	Orphan Designation	-
congenital primary megaureter, obstructed form	Monolaurin	Orphan Designation	-
developmental and epileptic encephalopathy, 40	Exosurf Neonatal for Intratracheal Suspension	Orphan Designation	-
human papillomavirus-related penile squamous cell carcinoma	Interferon alfa-nl	Orphan Designation	-
human papillomavirus-related squamous cell carcinoma	Interferon alfa-nl	Orphan Designation	-
idiopathic pulmonary arterial hypertension	Flolan	Orphan Designation	-
metastatic malignant neoplasm in the colon	Exosurf Neonatal for Intratracheal Suspension	Orphan Designation	-
metastatic malignant neoplasm in the lymph nodes	Exosurf Neonatal for Intratracheal Suspension	Orphan Designation	-
metastatic malignant neoplasm in the spinal cord	Exosurf Neonatal for Intratracheal Suspension	Orphan Designation	-
myopathy, distal, 7, adult-onset, X-linked	Epoprostenol	Orphan Designation	-
myopathy, myofibrillar, 13, with rimmed vacuoles	Epoprostenol	Orphan Designation	-
neurodevelopmental-craniofacial syndrome with variable renal and cardiac abnormalities	Alkeran For Injection	Orphan Designation	-
newborn respiratory distress syndrome	Exosurf Neonatal for Intratracheal Suspension	Orphan Designation	-
pulmonary hypertension, primary, 1	Flolan	Orphan Designation	-
pulmonary hypertension, primary, 2	Flolan	Orphan Designation	-
pulmonary hypertension, primary, 3	Flolan	Orphan Designation	-
pulmonary hypertension, primary, 4	Flolan	Orphan Designation	-
pulmonary hypertension, primary, 6	Flolan	Orphan Designation	-
respiratory distress syndrome in premature infants	Exosurf Neonatal for Intratracheal Suspension	Orphan Designation	-
stiff-person syndrome	Carbovir	Orphan Designation	-
thrombocytopenia 11 with multiple congenital anomalies and dysmorphic facies	Alkeran For Injection	Orphan Designation	-

← Back to Companies